PTGS2 and colorectal cancer: Moreover, an adjuvant chemotherapy trial carried out by Chan et al. in 1279 patients with stage I-III colorectal cancer showed that use of Aspirin after diagnosis of nonmetastatic colorectal cancer was associated with improved survival from the disease, particularly among individuals with primary tumors that overexpress COX-2 [12].